What recent paediatric guidelines mean for drug developers
Drug Discovery World
JULY 25, 2023
General clinical pharmacology This FDA draft guidance was previously issued in 2014 but was re-issued for comments again in 2022. The guidance covers three main areas: clinical pharmacology considerations, ethical considerations, and the paediatric study plan design including points to consider.
130 
Let's personalize your content